Arcadia Biosciences, Inc. (RKDA)
USD 5.87
(-0.51%)
USD 5.87
(-0.51%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 5.33 Million USD | -46.46% |
| 2022 | 9.95 Million USD | 46.84% |
| 2021 | 6.78 Million USD | -15.61% |
| 2020 | 8.03 Million USD | 587.25% |
| 2019 | 1.16 Million USD | -20.15% |
| 2018 | 1.46 Million USD | -63.64% |
| 2017 | 4.02 Million USD | 26.29% |
| 2016 | 3.18 Million USD | -41.12% |
| 2015 | 5.41 Million USD | -22.46% |
| 2014 | 6.98 Million USD | 7.78% |
| 2013 | 6.47 Million USD | -7.59% |
| 2012 | 7.01 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 1.25 Million USD | 7.26% |
| 2024 Q2 | 1.3 Million USD | 4.06% |
| 2023 Q3 | 1.59 Million USD | 14.97% |
| 2023 Q2 | 1.38 Million USD | -7.95% |
| 2023 FY | 5.33 Million USD | -46.46% |
| 2023 Q1 | 1.5 Million USD | 50.9% |
| 2023 Q4 | 1.17 Million USD | -26.74% |
| 2022 Q1 | 3.22 Million USD | 48.32% |
| 2022 Q2 | 3.85 Million USD | 19.81% |
| 2022 Q3 | 1.87 Million USD | -51.32% |
| 2022 FY | 9.95 Million USD | 46.84% |
| 2022 Q4 | 1 Million USD | -46.75% |
| 2021 Q3 | 2.37 Million USD | 69.11% |
| 2021 Q1 | 828 Thousand USD | -88.39% |
| 2021 FY | 6.78 Million USD | -15.61% |
| 2021 Q4 | 2.17 Million USD | -8.63% |
| 2021 Q2 | 1.4 Million USD | 69.69% |
| 2020 Q2 | 281 Thousand USD | -9.06% |
| 2020 FY | 8.03 Million USD | 587.25% |
| 2020 Q4 | 7.13 Million USD | 2170.7% |
| 2020 Q3 | 314 Thousand USD | 11.74% |
| 2020 Q1 | 309 Thousand USD | -25.72% |
| 2019 FY | 1.16 Million USD | -20.15% |
| 2019 Q3 | 392 Thousand USD | 93.1% |
| 2019 Q4 | 416 Thousand USD | 6.12% |
| 2019 Q1 | 158 Thousand USD | -64.41% |
| 2019 Q2 | 203 Thousand USD | 28.48% |
| 2018 Q1 | 214 Thousand USD | -85.01% |
| 2018 FY | 1.46 Million USD | -63.64% |
| 2018 Q4 | 444 Thousand USD | 20.0% |
| 2018 Q2 | 436 Thousand USD | 103.74% |
| 2018 Q3 | 370 Thousand USD | -15.14% |
| 2017 FY | 4.02 Million USD | 26.29% |
| 2017 Q1 | 1.01 Million USD | 88.52% |
| 2017 Q2 | 991 Thousand USD | -2.65% |
| 2017 Q3 | 589 Thousand USD | -40.57% |
| 2017 Q4 | 1.42 Million USD | 142.44% |
| 2016 Q1 | 852 Thousand USD | -36.7% |
| 2016 FY | 3.18 Million USD | -41.12% |
| 2016 Q4 | 540 Thousand USD | -49.77% |
| 2016 Q3 | 1.07 Million USD | 49.1% |
| 2016 Q2 | 721 Thousand USD | -15.38% |
| 2015 FY | 5.41 Million USD | -22.46% |
| 2015 Q3 | 1.82 Million USD | 27.48% |
| 2015 Q2 | 1.43 Million USD | 75.46% |
| 2015 Q1 | 815 Thousand USD | -70.87% |
| 2015 Q4 | 1.34 Million USD | -26.17% |
| 2014 Q1 | 1.37 Million USD | -31.22% |
| 2014 Q2 | 1.3 Million USD | -5.23% |
| 2014 Q3 | 1.5 Million USD | 15.1% |
| 2014 FY | 6.98 Million USD | 7.78% |
| 2014 Q4 | 2.79 Million USD | 86.28% |
| 2013 FY | 6.47 Million USD | -7.59% |
| 2013 Q4 | 2 Million USD | 9.88% |
| 2013 Q3 | 1.82 Million USD | 37.3% |
| 2013 Q1 | 1.32 Million USD | 0.0% |
| 2013 Q2 | 1.32 Million USD | 0.0% |
| 2012 FY | 7.01 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Bioceres Crop Solutions Corp. | 464.82 Million USD | 98.853% |
| Muliang Viagoo Technology, Inc. | 8.65 Million USD | 38.43% |
| N2OFF, Inc. | 263.44 Thousand USD | -1923.193% |
| Yield10 Bioscience, Inc. | 60 Thousand USD | -8783.333% |